A5093755628- Mobile Health and mHealth Applications
- Obstructive Sleep Apnea Research
- Vascular Anomalies and Treatments
- Tracheal and airway disorders
- Pulmonary Hypertension Research and Treatments
- Digital Mental Health Interventions
- Cardiovascular Issues in Pregnancy
Oulu University Hospital
2024-2025
University of Oulu
2024
Abstract Treatment patterns of pulmonary arterial hypertension (PAH) and chronic thromboembolic (CTEPH) in Finland are unknown. Guidelines now recommend early escalation treatment for PAH. We evaluated how well Finnish practice follows guidelines, initiations outcomes related. The patients cohort includes all PAH CTEPH diagnosed between 2008 2020 university hospitals. Drug therapy was analysed with medical/procedural history available, changes the 4‐tier comparative, prospective registry...
Background Sleep apnea is a significant public health disorder in Finland, with prevalence of 3.7%. Continuous positive airway pressure (CPAP) therapy the first-line treatment for moderate or severe sleep apnea. From November 18, 2019, all patients who started their CPAP at Oulu University Hospital were attached to digital care pathway (SA-DCP) and instructed on its use. Some still did not use SA-DCP although they had therapy. Objective We aimed study professionals’ (HCPs’) perspectives...
<sec> <title>BACKGROUND</title> Sleep apnea is a significant public health disorder in Finland, with prevalence of 3.7%. Continuous positive airway pressure (CPAP) therapy the first-line treatment for moderate or severe sleep apnea. From November 18, 2019, all patients who started their CPAP at Oulu University Hospital were attached to digital care pathway (SA-DCP) and instructed on its use. Some still did not use SA-DCP although they had therapy. </sec> <title>OBJECTIVE</title> We aimed...